Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2019-02-27 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Ytterligare kanadensiskt patentbeviljande för Episurf Medical
Regulatory Filings Classification · 95% confidence The document is a short press release written in Swedish announcing that the Canadian Patent Office intends to grant a patent to Episurf Medical for a design method related to their Episealer® Femoral Twin implant. It contains general company information, contact details, and a concluding statement about disclosure under EU market abuse regulation. This type of announcement, which is not a core financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP, DIRS), fits best into the general regulatory announcement category, as it is a disclosure of an intellectual property event. Given the options, it is not a standard financial filing, earnings release, or management discussion. It is a specific, non-financial regulatory disclosure. Since there is no specific code for 'Patent Grant Announcement', the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a mandatory public disclosure under market rules regarding a material event (patent grant). The document length is short, but it is the full content, not an announcement *of* another document.
2019-02-27 Swedish
Another Canadian patent approval for Episurf Medical
Legal Proceedings Report Classification · 99% confidence The document announces the receipt of a 'Notice of Allowance' for a Canadian patent related to surgical instruments. This is a specific announcement concerning intellectual property (IP) and technology protection. While 'IP' is not a primary code, the content is a specific regulatory/legal update regarding a patent, which is a form of intellectual property protection. It is not a financial report (10-K, IR, ER), a management change (MANG), or a director trade (DIRS). Given the options, this type of specific announcement about intellectual property rights or legal matters fits best under 'Legal Proceedings Report' (LTR) as it relates to the company's legal/proprietary standing, or potentially as a general 'Regulatory Filing' (RNS) if LTR is too narrow. However, since it is a specific announcement about a patent approval, which is a key asset/legal status, LTR is a plausible fit for significant legal/proprietary updates. Given the lack of a dedicated 'IP' category, and that patent approvals are often disclosed via regulatory channels, RNS (Regulatory Filings) serves as the most appropriate general category for non-financial, non-management specific regulatory updates that don't fit elsewhere, especially since it's a formal notice from a government office (CIPO). I will classify it as RNS as the most general fit for a specific regulatory notice that isn't financial or governance-related.
2019-02-27 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding, specifically a 'Sell' transaction by Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension. It explicitly states the 'Reason for major shareholding notification' and provides the resulting share quantities and percentages (e.g., 4.81%). This structure perfectly matches the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds.
2019-02-21 English
Episurf Medical reaches milestone of 500 implants
Regulatory Filings Classification · 95% confidence The document is a short announcement from Episurf Medical regarding reaching a milestone of 500 implants. It contains quotes from the CEO and Medical Advisor, company background, and contact information. Crucially, it concludes with a statement: "This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation." This structure—a brief operational update mandated by regulation—is characteristic of a general regulatory announcement that doesn't fit the specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS). Since it is a general regulatory disclosure that doesn't fit other specific types, the most appropriate fallback category is Regulatory Filings (RNS). The document length (2189 chars) is short, but it is the report itself (the announcement), not an announcement *of* another report, so RPA is less fitting than RNS for this type of mandatory disclosure.
2019-02-20 English
Episurf Medical når milstolpe om 500 implantat
Regulatory Filings Classification · 95% confidence The document is a short announcement from Episurf Medical regarding achieving a milestone (500th implant surgery) and includes quotes from the CEO and a medical advisor. It is not a full financial report (10-K, IR), a detailed presentation (IP), or a transcript (CT). It is a specific operational/business update. Since it announces a significant event and is short, it fits best as a general regulatory announcement or news release. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, non-financial-specific operational press release that doesn't fit the other specific categories like DIV, ER, or MANG. The final paragraph confirms it is information the company is obligated to make public under EU market abuse regulation, suggesting a regulatory disclosure, but RNS serves as the general regulatory announcement category here.
2019-02-20 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding by a specific holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') concerning the issuer ('Episurf Medical AB'). It explicitly states the 'Reason for major shareholding notification Sell' and provides detailed figures for shares held before and after the transaction, including resulting percentages (e.g., 5.14% directly held shares, 4.96% indirectly held voting rights). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2019-02-19 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.